Huitinga I, Schmidt E D, van der Cammen M J, Binnekade R, Tilders F J
Graduate School Neurosciences Amsterdam, Research Institute Neurosciences Vrije Universiteit, Faculty of Medicine, Department of Pharmacology and The Netherlands Institute for Brain Research, Amsterdam, The Netherlands.
J Neuroendocrinol. 2000 Dec;12(12):1186-93. doi: 10.1046/j.1365-2826.2000.00574.x.
Lewis rats exhibit multiple defects in their hypothalamus-pituitary-adrenal (HPA) system that are considered to play a causal role in the susceptibility of this strain to autoimmune diseases, i.e. experimental allergic encephalomyelitis (EAE). In the present study, we aimed to modulate the HPA response of the Lewis rat and establish its consequences for the susceptibility to EAE. Because in Wistar rats, single administration of interleukin (IL)-beta (priming) is known to induce long-lasting (weeks) sensitization of HPA responses to stressors and immune stimuli, Lewis rats were given a single dose of hIL-1beta or vehicle 1 week prior to induction of EAE by immunization with myelin basic protein (MBP). Subsequently, neurological deficits were monitored once daily. The results show that IL-1 priming markedly suppresses the neurological symptoms of EAE, without affecting the onset or duration of the disease. Measurement of vasopressin and corticotropin releasing hormone (CRH) in the external zone of the median eminence revealed that, as compared to Wistar rats, Lewis rats exhibit low vasopressin but identical CRH, and that IL-1 priming increases (0.001) vasopressin without affecting CRH stores, which is consistent with a shift to vasopressin-dominated control of adrenocorticotropic hormone (ACTH) secretion as described in Wistar rats under conditions of HPA hyper(re)activity. However, IL-1 priming did not affect a.m. corticosterone levels following immunization with MBP or during the clinical phase of EAE. IL-1 priming of Lewis rats attenuated the ACTH responses to an IL-1 challenge 11 days later, which may relate to an increase in resting corticosterone levels. Thus, the mechanisms underlying IL-1 induced suppression of EAE are not related to enhanced HPA responses. In addition, we did not find IL-1 priming-induced alterations in MBP-specific immunoglobulin (Ig)M, IgG1, IgGa and IgGb plasma titres, or gross alterations in T cell activation as reflected in spontaneous or concanavalin-induced T cell proliferation. We therefore speculate that IL-1-induced elevation of resting corticosterone levels may influence the development of EAE.
刘易斯大鼠的下丘脑 - 垂体 - 肾上腺(HPA)系统存在多种缺陷,这些缺陷被认为在该品系对自身免疫性疾病(即实验性变态反应性脑脊髓炎,EAE)的易感性中起因果作用。在本研究中,我们旨在调节刘易斯大鼠的HPA反应,并确定其对EAE易感性的影响。因为在Wistar大鼠中,单次给予白细胞介素(IL)-β(预刺激)已知会诱导HPA对应激源和免疫刺激的反应产生持久(数周)的致敏作用,所以在通过用髓鞘碱性蛋白(MBP)免疫诱导EAE前1周,给刘易斯大鼠单次注射人IL-1β或赋形剂。随后,每天监测神经功能缺损情况。结果表明,IL-1预刺激显著抑制了EAE的神经症状,但不影响疾病的发病或持续时间。对正中隆起外侧区的加压素和促肾上腺皮质激素释放激素(CRH)的测量显示,与Wistar大鼠相比,刘易斯大鼠的加压素水平较低,但CRH水平相同,并且IL-1预刺激会增加(0.001)加压素水平,而不影响CRH储备,这与Wistar大鼠在HPA高(再)活性条件下所描述的促肾上腺皮质激素(ACTH)分泌向以加压素为主的控制转变一致。然而,IL-1预刺激在MBP免疫后或EAE临床阶段并未影响上午的皮质酮水平。刘易斯大鼠的IL-1预刺激在11天后减弱了对IL-1刺激的ACTH反应,这可能与静息皮质酮水平的升高有关。因此,IL-1诱导的EAE抑制机制与增强的HPA反应无关。此外,我们未发现IL-1预刺激引起MBP特异性免疫球蛋白(Ig)M、IgG1、IgGa和IgGb血浆滴度的改变,也未发现如自发或伴刀豆球蛋白诱导的T细胞增殖所反映的T细胞活化的明显改变。因此,我们推测IL-1诱导的静息皮质酮水平升高可能会影响EAE的发展。